Bromodomain testis associated pseudogene 1 (BRDTP1)

Bromodomain testis associated pseudogene 1 (BRDTP1) is listed as a pseudogene based on current gene annotations. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements required for expression. BRDTP1 is not recognized as a therapeutic target, receptor, enzyme, transporter, or ion channel, and does not belong to any druggable protein family[3]. There is no evidence linking BRDTP1 to established biological functions, disease roles, or pharmacological drug interactions; therefore, it does not meet standard criteria as a biomedically relevant molecule or receptor. If you intended a bromodomain-containing protein (such as BRDT, BRD1, BRD2, BRD3, BRD4), these are bona fide proteins involved in chromatin regulation and are targeted by bromodomain inhibitors in oncology and epigenetic therapy[3]. However, BRDTP1 remains a pseudogene, and its name may occasionally be confused with functional bromodomain family members. Key point: BRDTP1 is a pseudogene, not a validated molecular target, and is not used in therapeutic, diagnostic, or mechanistic drug research. If you require details for a specific functional bromodomain protein, please clarify.

Other names

bromodomain, testis-specific pseudogene 1hCG1811337BRDTP1